imatinib mesylate has been researched along with Retinal Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CK; Mohamed, S; Szeto, SK; Tsang, CW | 1 |
| Chen, B; Yan, X; Yang, H; Zhang, X | 1 |
| Bowles, K; Docherty, SM; Reza, M; Turner, G | 1 |
| Bergua, A; Chankiewitz, E; Mackensen, A; Scholz, GA; Spriewald, BM | 1 |
| Bajel, A; Bassili, S; Seymour, JF | 1 |
1 review(s) available for imatinib mesylate and Retinal Diseases
| Article | Year |
|---|---|
Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature.
Topics: Antineoplastic Agents; Blindness; Combined Modality Therapy; Humans; Imatinib Mesylate; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Leukostasis; Male; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2018 |
4 other study(ies) available for imatinib mesylate and Retinal Diseases
| Article | Year |
|---|---|
Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
Topics: Animals; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Retina; Retinal Diseases; Retinal Hemorrhage; Vision Disorders | 2023 |
Resolution of Roth spots in chronic myeloid leukaemia after treatment with imatinib.
Topics: Adult; Antineoplastic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Ophthalmoscopes; Protein Kinase Inhibitors; Retinal Diseases; Tomography, Optical Coherence; Treatment Outcome | 2015 |
[Fundus leucaemicus as first manifestation of chronic myeloid leukemia. Diagnosis and monitoring with OCT under treatment with imatinib and interferon-alpha].
Topics: Antineoplastic Agents; Benzamides; Drug Therapy, Combination; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myeloid; Male; Piperazines; Pyrimidines; Retinal Diseases; Tomography, Optical Coherence; Treatment Outcome; Young Adult | 2010 |
Safe treatment of a patient with CML using dasatinib after prior retinal oedema due to imatinib.
Topics: Adult; Benzamides; Dasatinib; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Retinal Diseases; Thiazoles | 2008 |